As of July 2026, 8 paid clinical trials are recruiting for Weight loss in Washington D.C., District of Columbia. Weight loss studies evaluate GLP-1, GIP, and other incretin-based therapies, novel metabolic drugs, and combined lifestyle programs aiming for sustained 10–25% weight reduction. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Washington D.C. has approximately 834 recruiting research studies across a wide range of therapeutic areas. District of Columbia hosts a diverse network of universities, academic medical centers, and community hospitals that run clinical trials across oncology, cardiology, neurology, and many other therapeutic areas.
Researchers run research studies in Washington D.C., DC at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| MedStar Washington Hospital Center | Breast Cancer, ARDS, ARDS (Acute Respiratory Distress Syndrome) | 96 |
| Children's National Medical Center | Diffuse Intrinsic Pontine Glioma, High Grade Glioma, Neuroblastoma | 92 |
| Children's National Hospital | Sickle Cell Disease, Asthma in Children, Hypochondroplasia | 79 |
| MedStar Georgetown University Hospital | Malignant Solid Neoplasm, Breast Cancer, Acute Myeloid Leukemia | 75 |
| Sibley Memorial Hospital | Bladder Cancer, Breast Cancer, Brain Tumor | 41 |
| Georgetown University | Amyotrophic Lateral Sclerosis, HIV, Huntington's Disease | 36 |
| Georgetown University Medical Center | Breast Cancer, Locally Advanced Solid Tumor, Metastatic Solid Tumor | 33 |
| George Washington University | HIV Infection, Advanced Solid Tumor, Advanced Solid Tumors | 19 |
| George Washington University Medical Center | Breast Cancer, Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma | 19 |
| Children's National Health System | Anesthesia, Atopy, Autoimmunity | 11 |
| Georgetown Lombardi Comprehensive Cancer Center | Solid Tumor, Acute Myeloid Leukemia (AML) in Remission, Adenocarcinoma of Biliary Tract | 11 |
| Kaiser Permanente-Capitol Hill Medical Center | Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Breast Cancer | 10 |
| Washington Hospital Center | AIDS, Acute or Chronic Coronary Artery Disease, Aortic Valve Disease | 9 |
| MedStar Health Research Institute | Cancer, Cancer Pain, Central Line Associated Blood Stream Infections (CLABSI) | 9 |
| MedStar National Rehabilitation Hospital | Neurogenic Bladder, Spinal Cord Injuries, Multiple Sclerosis | 8 |
| Childrens National Medical Center | Chronic Graft-versus-host-disease, Genetic Disease, Lymphatic Malformations | 7 |
| MedStar Health | Acute DVT of Lower Extremity, Acute Limb Ischemia, Arterial Embolism and Thrombosis | 7 |
| George Washington University Hospital | Abdominal Compartment Syndrome, Acute Kidney Injury, Atrial Fibrillation | 6 |
| Washington DC VA Medical Center, Washington, DC | Adult Growth Hormone Deficiency, Alcohol Use Disorder (AUD), BARD1, BRCA1, BRCA2, BRIP1, CHEK1, FANCL, PALB2 | 6 |
| Childrens National Hospital | Chronic Graft-versus-host-disease, Ewing Sarcoma, Familial Hypercholesterolemia - Heterozygous | 5 |
| Clinical Trial Site | AQP4+ NMOSD, Atypical Hemolytic-Uremic Syndrome, Generalized Myasthenia Gravis | 5 |
| GSK Investigational Site | HIV Infections, Multiple Myeloma, Neoplasms, Head and Neck | 5 |
| Children's National | Ablation, Becker Muscular Dystrophy, Cardiomyopathy | 4 |
| George Washington University Medical Faculty Associates | Controlled Human Infection, Cutaneous Squamous Cell Carcinoma (CSCC), Focal Segmental Glomerulosclerosis | 4 |
| Georgetown University Hospital | Interstitial Lung Disease, Primary Immune Thrombocytopenia (ITP), Progressive Pulmonary Fibrosis | 4 |
Recruiting trials in Washington D.C. grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Clinical trials in District of Columbia are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. District of Columbia research additionally follows state public health department oversight and any applicable state privacy statutes.
Hipa.ai aggregates every recruiting study in Washington D.C. from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
There are approximately 834 recruiting clinical trials in Washington D.C., District of Columbia listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in Washington D.C. compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in Washington D.C. include Breast Cancer (17), Sickle Cell Disease (12), Stroke (12), High Grade Glioma (9), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Washington D.C. on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in Washington D.C. include MedStar Washington Hospital Center, Children's National Medical Center, Children's National Hospital, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
The largest active categories in Washington D.C. are Cancer & tumors (286), Neurology & pain (67), Cardiovascular (50). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.